Trials / Completed
CompletedNCT07386613
Feasibility of Home Monitoring of Visual Function in DR
Investigating the Feasibility of Home Monitoring of Visual Function in Populations at High Risk of Developing Diabetic Retinopathy (DR) Using Novel Game-based Technology (OKKO Health)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Queen's University, Belfast · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Diabetes is a serious condition where patients can develop complications in their body including their eyes which can lead to sight loss. Patients with diabetes are encouraged to attend yearly screening appointments at which signs of Diabetic Retinopathy (DR) are assessed. Attendance at these appointments and at any follow-up appointments can be time-consuming and inconvenient for those working. Better ways to monitor changes in vision are needed. Therefore, we are hoping to develop a set of eye tests that a person with diabetes can complete at home on a smartphone in collaboration with researchers at OKKO Health.
Conditions
- Diabetes (DM)
- Diabetes Complication
- Diabetes (Insulin-requiring, Type 1 or Type 2)
- Diabetic Retinopathy (DR)
- Diabetes Pregnancy
- Gestational Diabetes Mellitus in Pregnancy
- Dialysis Patients
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Okko Health App | Okko Health digital health app used to assess visual acuity and contrast sensitivity using a mobile phone. |
Timeline
- Start date
- 2023-09-09
- Primary completion
- 2024-06-20
- Completion
- 2024-07-20
- First posted
- 2026-02-04
- Last updated
- 2026-02-04
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT07386613. Inclusion in this directory is not an endorsement.